Twins' mysterious deaths, middle age weight loss, summer TV preview: Catch up on the day's stories
👋 Welcome to 5 Things PM! Losing weight in middle age could set you up for a longer and healthier life, a new study found. The benefits include a lower risk of chronic diseases and death.
Here's what else you might have missed during your busy day:
1️⃣ Mystery solved: Twin 19-year-old brothers Qaadir and Naazir Lewis were found shot to death at the remote summit of a mountain in northern Georgia. Their deaths baffled the close-knit family for months, but police now say they know what happened.
2️⃣ 'A major issue': A sperm donor with a rare genetic mutation fathered 67 children, and now 10 of them have been diagnosed with cancer. Advocates say there's a need for greater regulation and a limit on the number of births allowed from a single donor.
3️⃣ You snooze, you lose? When jolted awake by a blaring alarm clock, it's tempting to reach for the snooze button. 'Just five more minutes' is practically a morning mantra. But you could be silently sabotaging your shut-eye. Experts explain the pros and cons.
4️⃣ What to watch: With the dog days of summer approaching, our entertainment team rounded up the best new series and movies coming to a TV screen near you, including a drama from the creator of 'Succession' and an Adam Sandler comedy sequel.
5️⃣ Gone viral: Archie and Miles Shephard used to work together as salesmen in a lumber yard. Now they're social media stars known for their high-energy and hilarious interpretations of some of the most dramatic moments in sports.
💥 Big boom: A home security camera captured the moment a box truck exploded while passing through a residential neighborhood in Addison, Illinois. The driver walked away with only minor injuries.
• RFK Jr. says Covid-19 shot will no longer be recommended for healthy children and pregnant women• Trump considers new sanctions on Russia as he grows more furious with Putin• NPR sues Trump over executive order to cut funding
🇩🇰 That's about to be the new retirement age in Denmark, and it's the highest in Europe.
🧀 Hole-y rollers: It's been described as the world's most dangerous race, and it's certainly one of the most ridiculous — people tumbling down a steep hill in pursuit of a wheel of Double Gloucester cheese. Contestants explain why it's so thrilling.
⚽ What's next? The Portuguese soccer star threw his future into doubt with a cryptic message on social media after scoring his 25th goal on the final day of the Saudi Pro League season.
📖 Whose voice narrates the audiobook version of first lady Melania Trump's memoir? A. Megyn KellyB. Barron TrumpC. Morgan FreemanD. Her own voice using AI⬇️ Scroll down for the answer.
🐼 Cute overload: Hong Kong's first locally born baby pandas — affectionately known as 'Elder Sister' and 'Little Brother' — finally have actual names after a contest that drew more than 35,000 entries. Take a look.
👋 We'll see you tomorrow. 🧠 Quiz answer: D. The first lady said her memoir is narrated 'entirely using artificial intelligence in my own voice.'📧 Check out all of CNN's newsletters.
5 Things PM is produced by CNN's Chris Good, Meghan Pryce, Kimberly Richardson and Morgan Severson.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Alexandria Ocasio-Cortez Gets Delightfully Catty On Trump-Musk Split
Rep. Alexandria Ocasio-Cortez (D-N.Y.) played the feud between President Donald Trump and former DOGE henchman Elon Musk for laughs on Thursday. (Watch the video below.) Approached by Spectrum News 1 about the fracture in their bromance, the smiling AOC said: 'Oh man, the girls are fighting, aren't they?' The progressive lawmaker could be forgiven for a little regressive humor. She has been one of the Democrats' most vocal opponents of Trump's so-called 'Big Beautiful Bill' ― the legislation that actually ignited the Trump-Musk row. Musk called the spending measure an abomination and once Trump finally expressed his disappointment in the Tesla magnate and Trump mega-donor, things turned personal between the two. The bill is being ironed out in the Senate and would reportedly ax 11 million people off Medicaid over time. Ocasio-Cortez had made a similar prediction last month. 'When this country wakes up in the morning, there will be consequences to pay for this,' she said at the time. But perhaps she didn't see the bill resulting in the breakup of DC's premier platonic power couple. For a moment anyway, it was something to crack wise about. AOC on Musk and Trump: "the girls are fighting aren't they ?"💀 — Winter Politics (@WinterPolitics1) June 6, 2025 Stephen Colbert Spots The Musk-Trump Feud Moment That Proves 'Things Are Bad' 1 Subtle Barb In Trump-Musk Blow-Out Has Dana Bash Saying 'Wow, Wow, Wow' 'My Prediction': Jimmy Kimmel Reveals Ugly Next Phase Of Trump-Musk Feud
Yahoo
24 minutes ago
- Yahoo
Who would want to have babies under a Trump administration? Not me.
Despite declarations that something needs to be done about the declining birth rate in the United States, neither President Donald Trump nor the Republican Party has the desire to protect pregnant people. If they did, the Trump administration wouldn't have made its latest move to restrict abortion nationwide. On Tuesday, June 3, the Centers for Medicare and Medicaid Services rescinded a Biden-era policy that directed hospitals to provide emergency abortions if it was needed to stabilize a pregnant patient. The guidance and communications on it apparently 'do not reflect the policy of this Administration.' I, like many people who support abortion rights, know what this will lead to. It means more pregnant people will die. Does that reflect the policy of the administration? The Biden policy was implemented in 2022, following the fall of Roe v. Wade, and argued that hospitals receiving Medicare funding had to comply with the Emergency Medical Treatment and Active Labor Act (EMTALA). The former administration argued that this included providing emergency abortions when they were needed to stabilize a patient, even in states that had severe abortion restrictions. Opinion: A brain dead pregnant Georgia woman is a horror story. It's Republicans' fault. This wasn't entirely a surprise. In 2024, the Supreme Court ruled that Texas could ban virtually all abortions in the state, including abortions that would have occurred under the old EMTALA guidelines. Still, it's terrifying to see this crucial policy eliminated. It's already dangerous to be pregnant in the United States. Our maternal mortality rate is much higher than in other wealthy countries. Same with our infant mortality rate. This will only exacerbate these tragedies. In states with abortion bans, the risks are even greater. A study from the Gender Equity Policy Institute found that people living in states with abortion bans were twice as likely to die during or shortly after childbirth. This is also backed by anecdotal evidence, including the 2022 deaths of two women in Georgia after the state passed a six-week ban. A different study found that infant mortality rates increased in states with severe restrictions on abortion, including an increase in deaths due to congenital anomalies. The Trump administration does not care about what is medically necessary to save someone's life. They don't care about whether the children supposedly saved by rescinding this policy will grow up without their mother. They care about their perceived moral superiority. They care about controlling women. Why would anybody want to have a child under that Republican way of thinking? Opinion: We're worrying about the wrong thing. Low birth rate isn't the crisis: Child care is. I want to say I'm surprised that the Trump administration would allow women in need of emergency care to die. Yet this is clearly aligned with the Republican stance on abortion, just like it's aligned with the actions that the party has taken to make it harder for women to access necessary care. Opinion alerts: Get columns from your favorite columnists + expert analysis on top issues, delivered straight to your device through the USA TODAY app. Don't have the app? Download it for free from your app store. Whether you like it or not, abortion is a necessary part of health care. It saves lives. Alexis McGill Johnson, the president and CEO of Planned Parenthood, laid it out plainly. 'Women have died because they couldn't get the lifesaving abortion care they needed,' she said in a statement. 'The Trump administration is willing to let pregnant people die, and that is exactly what we can expect." Again, this is the administration that wants young women like me to have children and improve the country's birth rate. This is an administration that claims to care about women and children. I know I wouldn't want to have a child while Trump continues to make it unsafe to be pregnant and give birth. I hate that this is the reality. Follow USA TODAY columnist Sara Pequeño on X, formerly Twitter, @sara__pequeno You can read diverse opinions from our USA TODAY columnists and other writers on the Opinion front page, on X, formerly Twitter, @usatodayopinion and in our Opinion newsletter. This article originally appeared on USA TODAY: Trump just made healthcare more dangerous for pregnant women | Opinion
Medscape
26 minutes ago
- Medscape
Year-Long Methotrexate Not Helpful for Inflammatory Knee OA
Compared with placebo, low-dose methotrexate administered weekly at doses up to 15 mg for 52 weeks did not relieve knee pain or reduce the size of effusion-synovitis in patients with inflammatory knee osteoarthritis (OA). METHODOLOGY: Researchers in China conducted a multicenter, clinical trial between July 2019 and January 2023 to examine whether low-dose methotrexate can reduce knee pain and effusion-synovitis in knee OA. They included 215 patients (mean age, 60.6 years; 89% women) with inflammatory knee OA and effusion-synovitis who were randomly assigned to receive either methotrexate or placebo, with weekly 5 mg folic acid supplementation given 1 day after treatment. Participants continued their regular medications (except corticosteroids and anti-synovitis drugs), did not take trimethoprim, and avoided alcohol during the trial. Primary outcomes were changes in knee pain on the visual analog scale (VAS) and inflammation measured by the effusion-synovitis maximal area on MRI over 52 weeks. Secondary outcomes were assessment of pain, stiffness, and physical function; changes in infrapatellar fat pad signal intensity; and evaluation of response to the assigned treatment. TAKEAWAY: At week 52, no significant difference was found between methotrexate and placebo groups in terms of VAS pain and effusion-synovitis maximal area (between-group difference, 0.3 mm; 95% CI, -6.7 to 7.3 mm and 0.1 cm 2 ; 95% CI, -0.8 to 1.0 cm 2 , respectively). ; 95% CI, -0.8 to 1.0 cm , respectively). No significant differences were observed between the two groups in terms of any of the prespecified secondary outcomes. The frequency of experiencing at least one adverse event was comparable between the methotrexate and placebo groups (29.6% and 24.3%, respectively); however, elevated concentrations of liver enzymes were more common in the methotrexate group. IN PRACTICE: 'Given the lack of efficacy of MTX [methotrexate] across knee OA studies and the known potential adverse events, it is not recommended for the treatment of painful, inflammatory knee OA. We now need to focus our attention on treatments that can both inhibit joint inflammation and stimulate chondrocytes within the cartilage to synthesize replacement matrix. The future of pharmaceuticals for knee OA needs to move past MTX,' Nancy E. Lane, MD, UC Davis Health, Sacramento, California, wrote in an accompanying editorial. SOURCE: This study was led by Zhaohua Zhu, PhD, Zhujiang Hospital, Southern Medical University, Guangzhou, China. It was published online on June 2, 2025, in JAMA Internal Medicine . LIMITATIONS: This study was conducted during COVID-19 shutdowns, which delayed recruitment and potentially increased loss to follow-up and nonadherence rates. The findings may not be fully generalizable because most participants were women, and racial and ethnic diversity was limited. The relatively small number of participants in each subgroup may have limited the ability to detect significant benefits in specific populations. DISCLOSURES: This study received funding from the National Key Research and Development Program of China, the National Natural Science Foundation of China, and the Clinical Research Startup Program of Southern Medical University. One author reported providing consulting advice on scientific advisory boards for various pharmaceutical companies outside the submitted work.
